INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-2238837244-compliance-meeting-regulation-regulatory]( "Why CMC Continuity Is The Missing Link Between Development And Manufacturing")
Why CMC Continuity Is The Missing Link Between Development And ManufacturingDiscover why CMC continuity is the missing link between development and manufacturing, and how preserving connected product and process knowledge helps reduce handoff risk, accelerate tech transfer, and strengthen manufacturing readiness.
-
![GettyImages-1293772957-scientist-laboratory-computer-drug-development]( "Techniques For PEGylation Site Identification")
Techniques For PEGylation Site IdentificationExamine how our innovative methods enable the precise identification of PEGylation sites, unlocking deeper insights into the structure, stability, and function of biotherapeutics.
-
![Eliminate Risk From Your Viral Vector Tech Transfers: Proven Strategies And Best Practices]( "Eliminate Risk From Your Viral Vector Tech Transfers")
Eliminate Risk From Your Viral Vector Tech TransfersExplore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.
-
![cdmo-solid-dose-GettyImages-1432665138]( "Choosing The Best Amorphous Dispersion Path Before It Costs You")
Choosing The Best Amorphous Dispersion Path Before It Costs YouParallel screening across multiple solid dispersion platforms early optimizes drug solubility and stability, building a strong technical foundation that prevents costly development delays.
-
Making Accelerated Predictive Stability Studies Even Faster With Software6/18/2026
Drug stability depends on environmental conditions, but testing every scenario experimentally isn’t practical. Accelerated predictive stability uses mathematical modeling to forecast degradation, helping scientists make faster, data-driven decisions early in development.
-
LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting7/29/2025
Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.
-
The Simplest, Most Powerful Digital PCR Workflow Family3/26/2026
Scalable digital PCR provides high-throughput automation for up to 384 samples. Support seven-color multiplexing and 3D data analysis to achieve superior sensitivity and streamlined laboratory workflows.
-
The Need For Speed: Early-Stage Dosage Form Development9/23/2026
The right formulation strategy can accelerate clinical timelines and set the stage for successful later-phase development.
-
Complete Your Journey To Therapeutic Success8/17/2026
Explore integrated workflows for peptide identification, impurity analysis, sequence confirmation, and characterization, supported by advanced technology and expert guidance to improve productivity.
DRUG DEVELOPMENT SOLUTIONS
-
![Waters ACQUITY QDa]( "Mass Detection For Undergraduates")
Allow you students to gain practical hands-on experience exploring the following fundamentals of mass spectrometry:
-
![Scientists working laboratory-GettyImages-1441663123]( "Tailored Process Development Services Designed For Success")
Explore the design services offered by the Gibco Media by Design team including cell line development, media and feed panel evaluations, bioproduction analytics and more.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Programs To Bridge Molecules From Discovery Into Clinical Development")
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
![iStock-843765220-pill-glove]( "Small is Powerful")
Explore best-in-class nanoforming services and how this company works with partners to find ground-breaking solutions that enhance drug effectiveness and targeting.
-
![scientists chemists laboratory-GettyImages-1055312560]( "Accelerate Molecules Through Development With Translational Pharmaceutics®")
By leveraging real-time data and operational efficiency, we accelerate timelines — manufacturing and releasing drug products in under seven days and reducing development cycles by up to 12 months.
